GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » GF Value

Cognetivity Neurosciences (XCNQ:CGN) GF Value : C$0.00 (As of Jun. 12, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cognetivity Neurosciences GF Value?

The GF Value represents the current intrinsic value of a stock derived from our exclusive method. The GF Value Line on our summary page gives an overview of the fair value that the stock should be traded at. It is calculated based on three factors:

  1. Historical multiples (PE Ratio, PS Ratio, PB Ratio and Price-to-Free-Cash-Flow) that the stock has traded at.
  2. GuruFocus adjustment factor based on the company’s past returns and growth.
  3. Future estimates of the business performance.

We believe the GF Value Line is the fair value that the stock should be traded at. The stock price will most likely fluctuate around the GF Value Line. If the stock price is significantly above the GF Value Line, it is overvalued and its future return is likely to be poor. On the other hand, if it is significantly below the GF Value Line, its future return will likely be higher.

Please note, "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

As of today (2024-06-12), Cognetivity Neurosciences's share price is C$0.01. Cognetivity Neurosciences's GF Value is C$0.00. Therefore, Cognetivity Neurosciences's Price-to-GF-Value for today is .

Based on the relationship between the current stock price and the GF Value, GuruFocus believes Cognetivity Neurosciences is Not Valued.

Cognetivity Neurosciences  (XCNQ:CGN) GF Value Explanation

Based on the relationship between the current stock price and the GF Value, GuruFocus provides the following 6 evaluations:

Posssible Evaluations All-in-One Screener Examples (2)
Possible Value Trap, Think Twice (1)Predictable Companies that possibly be Value Traps
Significantly OvervaluedPredictable Companies which are Significantly Overvalued
Modestly OvervaluedPredictable Companies which are Modestly Overvalued
Fairly ValuedPredictable High Quality Companies which are Fairly Valued
Modestly Undervalued (3)Predictable High Quality Companies which are Modestly Undervalued
Significantly Undervalued (3)Predictable High Quality Companies which are Significantly Undervalued

(1) "Possible Value Trap, Think Twice" is for the companies that look very undervalued, but either in the long term trend of business decline, or in financial distress.

(2) These are some simple examples. You can access our GF Valuation filter under All-in-One Screener’s Fundamental tab, and Price-to-GF-Value filter under Valuation Ratio tab and set your own criteria.

(3) There is only a sufficient margin of safety when the stock is undervalued.

Cognetivity Neurosciences's Price-to-GF-Value for today is calculated as

Price-to-GF-Value=Share Price/GF Value
=0.01/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cognetivity Neurosciences GF Value Related Terms

Thank you for viewing the detailed overview of Cognetivity Neurosciences's GF Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Cognetivity Neurosciences (XCNQ:CGN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Cognetivity Neurosciences Ltd (XCNQ:CGN) » Definitions » GF Value
Comparable Companies
TSXV:CDX TSXV:NURS XCNQ:AIML XCNQ:UDOC TSXV:NEWU XCNQ:NDAT TSXV:CRBK XCNQ:MOSS TSXV:CSPN TSXV:KOVO VEEV GEHC TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY EVH
Traded in Other Exchanges
CGNSF:USA 1UB:Germany
Address
800 West Pender Street, Suite 1430, Vancouver, BC, CAN, V6C 2V6
Website
https://www.cognetivity.com
Cognetivity Neurosciences Ltd is a technology company developing a cognitive testing platform, the Integrated Cognitive Assessment (ICA), for use in medical, commercial, and consumer environments for potentially allowing early diagnosis of dementia. The Company is considered operating in one segment for development of the ICA platform. Its geographical areas include Canada, United Kingdom and Dubai.
Executives
Ravinder Kang Director

Cognetivity Neurosciences (XCNQ:CGN) Headlines

No Headlines